Trial Summary
What is the purpose of this trial?
To determine the feasibility of a group-based education intervention to improve adherence to recommend surveillance and risk reducing procedures, with a focus at medically underserved women and racial/ethnic minorities with BRCA 1 and 2.
Research Team
Jose Rauh-Hain, MD
Principal Investigator
M.D. Anderson Cancer Center
Eligibility Criteria
This trial is for medically underserved women and racial/ethnic minorities who have BRCA 1 or 2 gene mutations, which are linked to a higher risk of cancer. Participants should be interested in learning about surveillance and procedures to reduce their cancer risk.Inclusion Criteria
Serum biochemical values within specified limits
My MDS is intermediate/high/very high risk and I've had 0-2 treatments.
I have AML that has come back or didn't respond to treatment, and I'm on my first or second attempt at salvage therapy.
See 10 more
Exclusion Criteria
I do not have any severe or uncontrolled medical conditions.
I had an organ transplant less than 3 months ago.
My condition is currently active and not under control.
See 9 more
Treatment Details
Interventions
- Education Content (Behavioural Intervention)
Trial OverviewThe study is testing an educational program delivered through group sessions. The goal is to see if this intervention can help participants follow recommended health screenings and preventive measures more closely.
Participant Groups
2Treatment groups
Experimental Treatment
Group I: Standard of CareExperimental Treatment1 Intervention
Participants will be randomized into one of two arms through REDCap
Group II: ACT-Together InterventionExperimental Treatment1 Intervention
Participants will be randomized into one of two arms through REDCap
Find a Clinic Near You
Who Is Running the Clinical Trial?
M.D. Anderson Cancer Center
Lead Sponsor
Trials
3,107
Recruited
1,813,000+
Dr. Peter WT Pisters
M.D. Anderson Cancer Center
Chief Executive Officer since 2017
MD from University of Western Ontario
Dr. Jeffrey E. Lee
M.D. Anderson Cancer Center
Chief Medical Officer
MD from Stanford University School of Medicine